TOMASSINI, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 1.310
EU - Europa 697
AS - Asia 444
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 1
Totale 2.463
Nazione #
US - Stati Uniti d'America 1.307
SG - Singapore 338
IE - Irlanda 268
IT - Italia 153
RU - Federazione Russa 77
SE - Svezia 70
CN - Cina 44
GB - Regno Unito 39
VN - Vietnam 33
DE - Germania 17
FI - Finlandia 12
UA - Ucraina 11
AU - Australia 8
FR - Francia 8
HK - Hong Kong 8
BE - Belgio 7
CZ - Repubblica Ceca 7
ES - Italia 6
IN - India 6
TR - Turchia 6
IR - Iran 5
BG - Bulgaria 4
CH - Svizzera 3
RO - Romania 3
CA - Canada 2
EU - Europa 2
MD - Moldavia 2
PK - Pakistan 2
PT - Portogallo 2
AT - Austria 1
CL - Cile 1
DK - Danimarca 1
EE - Estonia 1
JP - Giappone 1
MC - Monaco 1
ME - Montenegro 1
MN - Mongolia 1
NL - Olanda 1
NZ - Nuova Zelanda 1
PA - Panama 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 2.463
Città #
Singapore 298
Chandler 286
Dublin 266
Ashburn 104
Jacksonville 83
Princeton 82
Santa Clara 82
Altamura 41
Los Angeles 34
Beijing 33
Dong Ket 33
Wilmington 29
Washington 20
Chieti 17
Rome 16
Ann Arbor 15
Seattle 15
Falls Church 12
Boardman 11
Moscow 10
New York 10
Milan 9
Fairfield 8
Hong Kong 8
Southend 8
Brussels 7
Chicago 7
Helsinki 7
Pescara 7
Saint Petersburg 7
Woodbridge 7
London 6
Norwalk 6
Santander 6
Sydney 6
Cardiff 5
Nanchang 5
Oxford 5
Pune 5
Tehran 5
Brno 4
Camerino 4
Edinburgh 4
Frankfurt am Main 4
Houston 4
Izmir 4
Hanover 3
Lappeenranta 3
Menlo Park 3
Nuremberg 3
San Vito Chietino 3
Bosio 2
Cambridge 2
Cedar Lake 2
Città Sant'Angelo 2
Dearborn 2
Elk Grove Village 2
Florence 2
Iasi 2
Melbourne 2
Munich 2
Olomouc 2
Pianella 2
Pisa 2
Pontecorvo 2
Sofia 2
Toritto 2
Vetroz 2
Alba Adriatica 1
Amsterdam 1
Auckland 1
Bratislava 1
Buffalo 1
Burgas 1
Campobasso 1
Campodipietra 1
Chisinau 1
Clearwater 1
Copenhagen 1
Cormeilles-en-Parisis 1
Dongguan 1
Forest City 1
Hamminkeln 1
Hangzhou 1
Isernia 1
Istanbul 1
Jiaxing 1
Kagoya 1
L'aquila 1
Lanciano 1
Las Vegas 1
Lisbon 1
Lucca 1
L’Aquila 1
Miami 1
Monaco 1
Montesilvano Marina 1
Mountain View 1
Newark 1
Nottingham 1
Totale 1.726
Nome #
Modelling the natural history of primary progressive multiple sclerosis 76
Testosterone amplifies excitotoxic damage of cultured oligodendrocytes. 74
Comparing MRI metrics to quantify white matter microstructural damage in multiple sclerosis 70
A flow-diffusion model of oxygen transport for quantitative mapping of cerebral metabolic rate of oxygen (CMRO2) with single gas calibrated fMRI 68
Neuroplasticity and motor rehabilitation in multiple sclerosis 67
Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients with Multiple Sclerosis 66
A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy 65
Oral contraceptives combined with interferon b in multiple sclerosis 63
Brain morphometry in Multiple Sclerosis 63
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 62
Tractography in the presence of multiple sclerosis lesions 62
Relationship between Prolactin Plasma Levels and White Matter Volume in Women with Multiple Sclerosis 62
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study 61
Assessment of the Effects of Aerobic Fitness on Cerebrovascular Function in Young Adults Using Multiple Inversion Time Arterial Spin Labeling MRI 57
Dual-calibrated fMRI measurement of absolute cerebral metabolic rate of oxygen consumption and effective oxygen diffusivity 56
Neurological update: MOG antibody disease 53
Informing MS patients on treatment options: a consensus on the process of consent taking 53
Neurovascular Coupling During Visual Stimulation in Multiple Sclerosis: A MEG-fMRI Study 52
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study 52
How common is truly benign MS in a UK population? 51
The effect of inflammation and its reduction on brain plasticity in multiple sclerosis: MRI evidence 50
Site-specific clinical disease onset in multiple sclerosis 50
Predicting the profile of increasing disability in multiple sclerosis 50
Exergames for balance dysfunction in neurological disability: a meta-analysis with meta-regression 49
Impact of the 2017 revisions to McDonald criteria on the diagnosis of multiple sclerosis 47
Effect on Cognition of Estroprogestins Combined with Interferon Beta in Multiple Sclerosis: Analysis of Secondary Outcomes from a Randomised Controlled Trial 46
Cerebral Metabolic Changes During Visuomotor Adaptation Assessed Using Quantitative fMRI 45
Impaired Functional Connectivity Unmasked by Simple Repetitive Motor Task in Early Relapsing-Remitting Multiple Sclerosis 41
Contribution of metabolomics to multiple sclerosis diagnosis, prognosis and treatment 40
A frequency-domain machine learning method for dual-calibrated fMRI mapping of oxygen extraction fraction (OEF) and cerebral metabolic rate of oxygen consumption (CMRO 2) 38
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study 35
Diagnosis and management of multiple sclerosis: MRI in clinical practice 34
Corrigendum: A Frequency-Domain Machine Learning Method for Dual-Calibrated fMRI Mapping of Oxygen Extraction Fraction (OEF) and Cerebral Metabolic Rate of Oxygen Consumption (CMRO 2) 34
Cerebrovascular reactivity in multiple sclerosis is restored with reduced inflammation during immunomodulation 33
Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases 33
Harmonization of real-world studies in multiple sclerosis: Retrospective analysis from the rirems group 31
Neuroplasticity and functional recovery in multiple sclerosis 28
Predictors of training-related improvement in visuomotor performance in patients with multiple sclerosis: A behavioural and MRI study 28
A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgia 28
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study 27
Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment 26
Pathophysiology of multiple sclerosis damage and repair: Linking cerebral hypoperfusion to the development of irreversible tissue loss in multiple sclerosis using magnetic resonance imaging 26
Similarities and differences between multiple sclerosis and type 1 diabetes 26
Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS 25
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis 23
Age-related changes in grey and white matter structure throughout adulthood 21
Neutralizing and binding antibodies to IFN-beta: relative frequency in relapsing-remitting multiple sclerosis patients treated with different IFN-beta preparations 20
The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis 20
Breath-hold BOLD fMRI without CO2 sampling enables estimation of venous cerebral blood volume: potential use in normalization of stimulus-evoked BOLD fMRI data 20
Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability 19
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose 19
Diffusion-Weighted Imaging Tractography-Based Parcellation of the Human Parietal Cortex and Comparison with Human and Macaque Resting-State Functional Connectivity 19
Preservation of motor skill learning in patients with multiple sclerosis 18
Mechanisms of Network Changes in Cognitive Impairment in Multiple Sclerosis 18
Relating brain damage to brain plasticity in patients with multiple sclerosis 17
Guillain−Barré syndrome and SARS-CoV-2 infection: a systematic review and meta-analysis on a debated issue and evidence for the ‘Italian factor’ 17
Model-free characterization of brain functional networks for motor sequence learning using fMRI 17
Reduced brain oxygen metabolism in patients with multiple sclerosis: Evidence from dual-calibrated functional MRI 17
Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study 16
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study 16
Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis 16
Structural and functional bases for individual differences in motor learning 16
Post-marketing survey on clinical response to interferon beta in relapsing multiple sclerosis: the Roman experience 16
Cannabinoid-induced effects on the nociceptive system: a neurophysiological study in patients with secondary progressive multiple sclerosis 16
Guillain–Barré syndrome and COVID-19 vaccination: a systematic review and meta-analysis 16
Neutralizing antibodies explain the poor clinical response to interferon beta in a small proportion of patients with multiple sclerosis: a retrospective study 16
Evidence of impaired brain activity balance after passive sensorimotor stimulation in multiple sclerosis 16
Contemporary study of multiple sclerosis disability in South East Wales 16
The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis 15
A 6-year clinical and MRI follow-up study of patients with relapsing-remitting multiple sclerosis treated with Interferon-beta 15
Interferon beta treatment of MS in the daily clinical setting: a 3-year post-marketing study 15
Diffusion-weighted imaging tractography-based parcellation of the human lateral premotor cortex identifies dorsal and ventral subregions with anatomical and functional specializations 15
Multiple sclerosis lesions: insights from imaging techniques 14
Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial 13
Correction to: Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study 13
A tractometry principal component analysis of white matter tract network structure and relationships with cognitive function in relapsing-remitting multiple sclerosis 13
Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study 13
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study 13
Motor practice promotes increased activity in brain regions structurally disconnected after subcortical stroke 12
Distinct and overlapping functional zones in the cerebellum defined by resting state functional connectivity 12
Sex hormones modulate brain damage in multiple sclerosis: MRI evidence 11
Predictors of long-term clinical response to interferon beta therapy in relapsing multiple sclerosis 11
Progressive multifocal leukoencephalopathy or severe multiple sclerosis relapse following COVID-19 vaccine: a diagnostic challenge 11
Changes in brain perfusion with training-related visuomotor improvement in MS 11
Relationship between emotional distress in caregivers and health status in persons with multiple sclerosis 10
Alexithymia in multiple sclerosis: relationship with fatigue and depression 10
'Gender gap' in multiple sclerosis: magnetic resonance imaging evidence 10
Fate of neutralizing and binding antibodies to IFN beta in MS patients treated with IFN beta for 6 years 10
Monthly corticosteroids decrease neutralizing antibodies to IFNbeta1 b: a randomized trial in multiple sclerosis 10
Sex hormones, brain damage and clinical course of Multiple Sclerosis 9
Lessons from immunotherapies in multiple sclerosis 9
Changes of brain parenchyma free water fraction reflect tissue damage and impaired processing speed in multiple sclerosis 8
Sex hormones: a role in the control of multiple sclerosis? 5
Transverse myelitis in children and adults 5
Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride 5
Totale 2.826
Categoria #
all - tutte 15.217
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.217


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020214 0 0 0 1 1 1 3 3 31 104 57 13
2020/2021185 21 18 35 7 2 29 8 14 6 5 0 40
2021/2022209 1 1 3 3 8 12 3 37 25 5 17 94
2022/2023885 76 131 41 85 70 143 57 62 100 41 43 36
2023/2024624 52 21 55 19 31 178 115 41 13 33 14 52
2024/2025670 119 534 17 0 0 0 0 0 0 0 0 0
Totale 2.826